Viewing Study NCT03539393


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-25 @ 11:22 PM
Study NCT ID: NCT03539393
Status: AVAILABLE
Last Update Posted: 2025-07-23
First Post: 2018-05-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fremanezumab Compassionate Use Program for Pediatric Patients
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module